276 related articles for article (PubMed ID: 11604353)
41. Transplant of hematopoietic stem cells in childhood: where we are and where we are going.
Locatelli F; Burgio GR
Haematologica; 1998 Jun; 83(6):550-63. PubMed ID: 9676029
[TBL] [Abstract][Full Text] [Related]
42. Is our current strategy in manipulating hemopoiesis in autologous transplantation correct?
To LB
Stem Cells; 1993 Jul; 11(4):283-9. PubMed ID: 8104615
[TBL] [Abstract][Full Text] [Related]
43. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.
Basquiera AL; Abichain P; Damonte JC; Ricchi B; Sturich AG; Palazzo ED; García JJ
J Clin Apher; 2006 Jul; 21(2):92-5. PubMed ID: 16106446
[TBL] [Abstract][Full Text] [Related]
44. Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapy.
Scheding S; Bergmannn M; Rathke G; Vogel W; Brugger W; Kanz L
Haematologica; 2004 May; 89(5):630-1. PubMed ID: 15136238
[TBL] [Abstract][Full Text] [Related]
45. [Manipulation of hematopoietic stem cell grafts and their use in clinical practice].
Sumerauer D; Matĕjcková S; Hrubá A; Eckschlager T
Cas Lek Cesk; 2002 Jul; 141(13):411-6. PubMed ID: 12238028
[TBL] [Abstract][Full Text] [Related]
46. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
[TBL] [Abstract][Full Text] [Related]
47. Purging of peripheral blood stem cell grafts.
Gee A
Stem Cells; 1995 Dec; 13 Suppl 3():52-62. PubMed ID: 8747989
[TBL] [Abstract][Full Text] [Related]
48. Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission.
Strodtbeck D; Bornhäuser M; Hänel M; Lerche L; Schaich M; Illmer T; Thiede C; Geissler G; Herbst R; Ehninger G; Platzbecker U
Bone Marrow Transplant; 2005 Dec; 36(12):1083-8. PubMed ID: 16247435
[TBL] [Abstract][Full Text] [Related]
49. Ex vivo expansion of human peripheral blood progenitors.
Chabannon C; Herrera-Rodriguez D; Bardin F; Mouren M; Novakovitch G; Blaise D; Maraninchi D; Mannoni P
Nouv Rev Fr Hematol (1978); 1995; 37(6):351-8. PubMed ID: 8907631
[TBL] [Abstract][Full Text] [Related]
50. Management strategies for poor peripheral blood stem cell mobilization.
Moog R
Transfus Apher Sci; 2008 Jun; 38(3):229-36. PubMed ID: 18485822
[TBL] [Abstract][Full Text] [Related]
51. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
52. Mesenchymal stem cells rescue CD34+ cells from radiation-induced apoptosis and sustain hematopoietic reconstitution after coculture and cografting in lethally irradiated baboons: is autologous stem cell therapy in nuclear accident settings hype or reality?
Drouet M; Mourcin F; Grenier N; Delaunay C; Mayol JF; Lataillade JJ; Peinnequin A; Hérodin F
Bone Marrow Transplant; 2005 Jun; 35(12):1201-9. PubMed ID: 15821761
[TBL] [Abstract][Full Text] [Related]
53. [The methods used to collect hematopoietic stem cells].
Hequet O
Transfus Clin Biol; 2011 Apr; 18(2):230-4. PubMed ID: 21397542
[TBL] [Abstract][Full Text] [Related]
54. An ex vivo model of hematopoietic stem cell mobilization.
Kessinger A; O'Kane Murphy B; Jackson JD; Sharp JG
Cytotherapy; 2005; 7(6):463-9. PubMed ID: 16306007
[TBL] [Abstract][Full Text] [Related]
55. Lack of self-renewal capacity in Fancc-/- stem cells after ex vivo expansion.
Habi O; Delisle MC; Messier N; Carreau M
Stem Cells; 2005 Sep; 23(8):1135-41. PubMed ID: 16020692
[TBL] [Abstract][Full Text] [Related]
56. [Clinical study on single-dose rhG-CSF combined with chemotherapy in autologous peripheral blood stem cell transplantation].
Tian H; Zhou SY
Ai Zheng; 2002 Aug; 21(8):896-9. PubMed ID: 12478902
[TBL] [Abstract][Full Text] [Related]
57. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
[TBL] [Abstract][Full Text] [Related]
58. Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates.
Hanazono Y; Terao K; Shibata H; Nagashima T; Ageyama N; Asano T; Ueda Y; Kato I; Kume A; Hasegawa M; Ozawa K
J Gene Med; 2002; 4(5):470-7. PubMed ID: 12221639
[TBL] [Abstract][Full Text] [Related]
59. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates.
Shields LE; Gaur L; Delio P; Potter J; Sieverkropp A; Andrews RG
Stem Cells; 2004; 22(5):759-69. PubMed ID: 15342940
[TBL] [Abstract][Full Text] [Related]
60. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
